Yi-Bin Chen, MD

Articles

Expectations of Chronic GVHD Treatment

January 18th 2024

The panel reviews recent developments in treatments, therapeutic approaches post-transplant, and the importance of clear communication in navigating patient expectations.

Monitoring Patients with GVHD

January 18th 2024

Drs Yi-Bin Chen, Corey Cutler, Hannah Choe, and Mitchell Horwitz discuss challenges in detecting and diagnosing chronic GVHD. The panel advocates for vigilant communication, early detection, and ongoing patient education for comprehensive post-transplant care.

Phases of Pathophysiology of Chronic GVHD

January 11th 2024

The expert panel explores the immunological aspects of chronic GVHD, highlighting challenges in simultaneous management, addressing fibrosis, and emphasizing the importance of early intervention in evolving transplant care practices.

Acute Versus Chronic Graft-Versus-Host Disease (GVHD)

January 11th 2024

Drs Yi-Bin Chen, Corey Cutler, Hannah Choe, and Mitchell Horwitz distinguish acute from chronic graft-versus-host disease (GVHD), how such distinction has changed over the last decades, and provide an overview of consensus definitions for disease grading.

The Evolving Field of GVHD Treatment

April 13th 2023

Sophie Paczesny, MD, PhD, and Yi-Bin Chen, MD, share their expert perspectives on how the GVHD treatment landscape is evolving.

Key Investigational Approaches for Acute and Chronic GVHD

April 13th 2023

Drs Yi-Bin Chen and Sophie Paczesny highlight data from key investigational approaches presented at recent meetings.

Treatment Options for Steroid-Refractory Chronic GVHD

April 13th 2023

Yi-Bin Chen, MD, reviews the treatment options for patients with steroid-refractory chronic GVHD.

The Importance of Early Treatment of Chronic GVHD

April 13th 2023

Drs Paczesny and Chen explain the importance of treating chronic GVHD as early as possible, and whether steroids are still the standard first-line treatment.

Emerging Strategies for the Treatment of Acute GVHD

April 6th 2023

Sophie Paczesny, MD, PhD, and Yi-Bin Chen, MD, detail novel strategies under investigation for the treatment of acute GVHD.

Frontline Treatment Options for Acute GVHD

April 6th 2023

Experts discuss the current options for treating acute GVHD, including the use of corticosteroids and their management.

Diagnosis and Stratification of Acute and Chronic GVHD

March 31st 2023

Drs Yi-Bin Chen and Sophie Paczesny review the diagnosis and staging of both acute and chronic GVHD, and the challenges clinicians may encounter.

Common Prophylaxis Regimens for GVHD

March 31st 2023

Yi-Bin Chen, MD, shares the most common GVHD prophylaxis regimens, and which regimen he typically chooses for his patients with GVHD.

Incidence and Risk Factors of Acute and Chronic GVHD

March 23rd 2023

Dr Sophie Paczesny details the incidence of graft versus host disease (GVHD) in patients receiving allogeneic transplants, and Dr Yi-Bin Chen describes the differing risk factors for acute and chronic GVHD.

Indications for Allogeneic Stem Cell Transplantation in the Treatment of Hematological Malignancies

March 23rd 2023

Sophie Paczesny, MD, PhD, explains which malignancies allogeneic transplantation can be used as a potentially curative treatment approach, and which patients are best suited for transplant.

Dr. Chen on the Efficacy of Vedolizumab Prophylaxis for aGVHD in the GRAPHITE Trial

March 1st 2023

Yi-Bin Chen, MD, discusses key data on the use of vedolizumab in lower gastrointestinal acute Graft-Versus-Host Disease according to the phase 3 GRAPHITE study.

GvHD: Advice for Patients

February 17th 2023

Experts share their insights and advice on how to best communicate with patients who are actively dealing with acute or chronic GvHD.

Future of Chronic GvHD

February 17th 2023

A look into the future of chronic GvHD and which treatment options patients the panel is most excited about.

Treatment Options: Steroid-Refractory GvHD

February 10th 2023

Experts define and review treatment options for patients with chronic GvHD that are also steroid refractory.

Treatment Options for Chronic GvHD

February 10th 2023

Comprehensive discussion into the available treatment options for patients that present with chronic GvHD.

Defining Chronic Graft vs Host Disease (GvHD)

February 3rd 2023

Panel of oncologists define in chronic GvHD and review the typical presentation of a patient.